ATP inhibition significantly reduced the therapeutic efficacy of CD47-SIRPα ICB, and ATP administration largely rescued the failed efficacy of CD47-SIRPα ICB in IFNAR1 knockout tumors, suggesting that ATP is a major mediator downstream of tumor cell-intrinsic IFNAR signaling. The gene discussed is SIRPA; the disease is neoplasm.